Literature DB >> 18512079

Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Giorgio Sirugo1, Branwen J Hennig, Adebowale A Adeyemo, Alice Matimba, Melanie J Newport, Muntaser E Ibrahim, Kelli K Ryckman, Alessandra Tacconelli, Renato Mariani-Costantini, Giuseppe Novelli, Himla Soodyall, Charles N Rotimi, Raj S Ramesar, Sarah A Tishkoff, Scott M Williams.   

Abstract

Africa is the ultimate source of modern humans and as such harbors more genetic variation than any other continent. For this reason, studies of the patterns of genetic variation in African populations are crucial to understanding how genes affect phenotypic variation, including disease predisposition. In addition, the patterns of extant genetic variation in Africa are important for understanding how genetic variation affects infectious diseases that are a major problem in Africa, such as malaria, tuberculosis, schistosomiasis, and HIV/AIDS. Therefore, elucidating the role that genetic susceptibility to infectious diseases plays is critical to improving the health of people in Africa. It is also of note that recent and ongoing social and cultural changes in sub-Saharan Africa have increased the prevalence of non-communicable diseases that will also require genetic analyses to improve disease prevention and treatment. In this review we give special attention to many of the past and ongoing studies, emphasizing those in Sub-Saharan Africans that address the role of genetic variation in human disease.

Entities:  

Mesh:

Year:  2008        PMID: 18512079     DOI: 10.1007/s00439-008-0511-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  453 in total

Review 1.  Copy number variants and pharmacogenomics.

Authors:  Karim Ouahchi; Neal Lindeman; Charles Lee
Journal:  Pharmacogenomics       Date:  2006-01       Impact factor: 2.533

2.  Associations between the IL-4 -590 T allele and Plasmodium falciparum infection prevalence in asymptomatic Fulani of Mali.

Authors:  Manijeh Vafa; Bakary Maiga; Klavs Berzins; Masashi Hayano; Sandor Bereczky; Amagana Dolo; Modibo Daou; Charles Arama; Bourema Kouriba; Anna Färnert; Ogobara K Doumbo; Marita Troye-Blomberg
Journal:  Microbes Infect       Date:  2007-05-03       Impact factor: 2.700

Review 3.  When is "malaria" malaria? The different burdens of malaria infection, malaria disease, and malaria-like illnesses.

Authors:  K A Koram; M E Molyneux
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

4.  Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis.

Authors:  R Bellamy; C Ruwende; T Corrah; K P McAdam; H C Whittle; A V Hill
Journal:  Tuber Lung Dis       Date:  1998

Review 5.  The Duffy blood groups, vivax malaria, and malaria selection in human populations: a review.

Authors:  F B Livingstone
Journal:  Hum Biol       Date:  1984-09       Impact factor: 0.553

6.  Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.

Authors:  A López-Vázquez; A Miña-Blanco; J Martínez-Borra; P D Njobvu; B Suárez-Alvarez; M A Blanco-Gelaz; S González; L Rodrigo; C López-Larrea
Journal:  Hum Immunol       Date:  2005-03       Impact factor: 2.850

7.  The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya.

Authors:  Sarah H Atkinson; Tabitha W Mwangi; Sophie M Uyoga; Edna Ogada; Alex W Macharia; Kevin Marsh; Andrew M Prentice; Thomas N Williams
Journal:  Clin Infect Dis       Date:  2007-02-07       Impact factor: 9.079

8.  The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.

Authors:  M J Newport; A Allen; A A Awomoyi; S J Dunstan; E McKinney; A Marchant; G Sirugo
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

9.  Linkage analysis of susceptibility to leprosy type using an IBD regression method.

Authors:  C Wallace; J Fitness; B Hennig; L Sichali; L Mwaungulu; J M Pönnighaus; D K Warndorff; D Clayton; P E M Fine; A V S Hill
Journal:  Genes Immun       Date:  2004-05       Impact factor: 2.676

10.  Bacterial infection and trachoma in the gambia: a case control study.

Authors:  Matthew J Burton; Richard A Adegbola; Fabakary Kinteh; Usman N Ikumapayi; Allen Foster; David C W Mabey; Robin L Bailey
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

View more
  44 in total

1.  Genome-wide patterns of population structure and admixture in West Africans and African Americans.

Authors:  Katarzyna Bryc; Adam Auton; Matthew R Nelson; Jorge R Oksenberg; Stephen L Hauser; Scott Williams; Alain Froment; Jean-Marie Bodo; Charles Wambebe; Sarah A Tishkoff; Carlos D Bustamante
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 2.  African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping.

Authors:  Michael C Campbell; Sarah A Tishkoff
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

3.  Adjusting for population stratification in a fine scale with principal components and sequencing data.

Authors:  Yiwei Zhang; Xiaotong Shen; Wei Pan
Journal:  Genet Epidemiol       Date:  2013-10-05       Impact factor: 2.135

4.  Mannose-binding lectin and ficolin-2 do not influence humoral immune response to hepatitis B vaccine.

Authors:  Michael Osthoff; Elizabeth Irungu; Kenneth Ngure; Nelly Mugo; Katherine K Thomas; Jared M Baeten; Damon P Eisen
Journal:  Vaccine       Date:  2014-07-10       Impact factor: 3.641

Review 5.  Genetic variation in Toll-like receptors and disease susceptibility.

Authors:  Mihai G Netea; Cisca Wijmenga; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2012-05-18       Impact factor: 25.606

6.  Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya.

Authors:  Lyna Zhang; Donald Prather; Jodi Vanden Eng; Sara Crawford; Simon Kariuki; Feiko ter Kuile; Dianne Terlouw; Bernard Nahlen; Altaf A Lal; Laurence Slutsker; Venkatachalam Udhayakumar; Ya Ping Shi
Journal:  Malar J       Date:  2010-03-29       Impact factor: 2.979

7.  Construction of a large scale integrated map of macrophage pathogen recognition and effector systems.

Authors:  Sobia Raza; Neil McDerment; Paul A Lacaze; Kevin Robertson; Steven Watterson; Ying Chen; Michael Chisholm; George Eleftheriadis; Stephanie Monk; Maire O'Sullivan; Arran Turnbull; Douglas Roy; Athanasios Theocharidis; Peter Ghazal; Tom C Freeman
Journal:  BMC Syst Biol       Date:  2010-05-14

8.  The genetic structure and history of Africans and African Americans.

Authors:  Sarah A Tishkoff; Floyd A Reed; Françoise R Friedlaender; Christopher Ehret; Alessia Ranciaro; Alain Froment; Jibril B Hirbo; Agnes A Awomoyi; Jean-Marie Bodo; Ogobara Doumbo; Muntaser Ibrahim; Abdalla T Juma; Maritha J Kotze; Godfrey Lema; Jason H Moore; Holly Mortensen; Thomas B Nyambo; Sabah A Omar; Kweli Powell; Gideon S Pretorius; Michael W Smith; Mahamadou A Thera; Charles Wambebe; James L Weber; Scott M Williams
Journal:  Science       Date:  2009-04-30       Impact factor: 47.728

9.  An excess of rare genetic variation in ABCE1 among Yorubans and African-American individuals with HIV-1.

Authors:  D C Crawford; N Zheng; E C Speelmon; I Stanaway; M J Rieder; D A Nickerson; M J McElrath; J Lingappa
Journal:  Genes Immun       Date:  2009-08-06       Impact factor: 2.676

10.  Optineurin coding variants in Ghanaian patients with primary open-angle glaucoma.

Authors:  Yutao Liu; Stephen Akafo; Cecile Santiago-Turla; Claudia S Cohen; Karen R Larocque-Abramson; Xuejun Qin; Leon W Herndon; Pratap Challa; Silke Schmidt; Michael A Hauser; R Rand Allingham
Journal:  Mol Vis       Date:  2008-12-18       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.